Scientists at The Wistar Institute have discovered that a class of FDA-approved cancer drugs known as PARP1 inhibitors can ...

These findings highlight the dual roles of antioxidants in cancer. Their impact depends on cancer type, stage, and genetic ...

Recently, MYC has been shown to serve as a direct regulator of ribosome biogenesis and therefore coordinates protein synthesis. Could the regulation of ribosome biogenesis by MYC be necessary for ...

Researchers have uncovered a crucial enzyme responsible for a specific chemical modification linked to the growth of a severe subtype of acute myeloid ...

Researchers at KAIST in South Korea have discovered a new way to treat cancer. They can reprogram cancer cells to become normal cells. The technique u ...

Senhwa Biosciences begins patient dosing in NCI-sponsored pilot study of Pidnarulex pharmacodynamics in patients with advanced solid tumours: Taipei, Taiwan Thursday, July 17, 202 ...

Senhwa Biosciences, Inc. (TPEx: 6492), a new drug development company focusing on first-in-class therapeutics for oncology, rare diseases, and infectious diseases, today announced that its new drug ...

HotSpot Therapeutics, Inc., a biotechnology company pioneering the discovery and development of oral, small molecule ...

Researchers at The Wistar Institute have found that FDA-approved cancer drugs known as PARP1 inhibitors can effectively stop the growth of lymphomas driven by the Epstein-Barr virus (EBV), ...

A University of Minnesota Medical School-led research team has discovered that a cancer signaling pathway has previously ...